Anti-neutrophil cytoplasmic antibodies in generalized autoimmune diseases

International Archives of Allergy and Immunology

Volumn 109, Issue 3, 1996, Pages 201-206

  Schnabel, Armin ^a   Hauschildt, Stefanie ^a   Gross, Wolfgang L ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

Author keywords

Anti neutrophil cytoplasmic antibodies; Glomerulonephritis; Microscopic polyangiitis; Rheumatoid arthritis; Systemic lupus erythematosus; Vasculitis; Wegener s granulomatosis

Indexed keywords

AUTOANTIBODY; MYELOPEROXIDASE; NEUTROPHIL CYTOPLASMIC ANTIBODY; PROTEINASE;

ANTIBODY TITER; ANTIGEN SPECIFICITY; AUTOIMMUNITY; DIAGNOSIS; ENTERITIS; ETIOLOGY; GLOMERULONEPHRITIS; HUMAN; IMMUNOFLUORESCENCE; LIVER DISEASE; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; VASCULAR DISEASE; WEGENER GRANULOMATOSIS;

EID: 0030021753     PISSN: 10182438     EISSN: 14230097     Source Type: Journal    
DOI: 10.1159/000237238     Document Type: Article

References (32)

1. Gross WL, Schmitt WH, Csemok E: ANCA and associated diseases: Immunodiagnostic and pathogenetic aspects. Clin Exp Immunol 1993; 91:1-12.
2. van der Woude FJ: Anticytoplasmic antibodies in Wegener's granulomatosis. Lancet 1985:i:48.
3. Ciross WL, Liidemann G, Kiefer G, Lehmann H: Anticytoplasmic antibodies in Wegener's granulomatosis. Lancet 1986;i:806.
4. Rump JA. Schölmerich J, Gross V, Roth M, Hcl-fesrieder R. Rautmann A. Liidemann J. Gross WL, Peter HH: A new type of perinuclear antineutrophil cytoplasmic antibody (p-ANCA) in active ulcerative colitis but not in Crohn’s disease. Immunobiology 1990;181:406-413.
5. Kallenberg CGM, Mulder AHL, Cohen Tervaert JW: Antineutrophil cytoplasmic antibodies: A still-growing class of autoantibodies in inflammatory disorders. Am J Med 1992:93: 675-682.
6. Nölle B, Bliimke A, Liidemann J, Rautmann A, Gross WL: IgG-Subklassenverteilung bei We-gencrscher Granulomatose. Immun Infekt 1990;18:98-100.
7. Esnault VLM, Soleimani B, Keogan MT, Brownlee AA, Jayne DRW, Lockwood CM: Association of IgM with IgG ANCA in patients presenting with pulmonary hemorrhage. Kidney Int 1992:41:1304-1310.
8. Ronda N, Esnault VLM, Layward L, Sepe V, Allen A, Feehelly J, Lockwood CM: Antineutrophil cytoplasm antibodies (ANCA) of IgA isotype in adult Henoch-Schönlein purpura. Clin Exp Immunol 1994:95:49-55.
9. Audrain MAP, Baranger TAR, Lockwood CM, Esnault VLM: High immunoreactivity of lacto-ferrin contaminating commcrically purified myeloperoxidase. J Immunol Methods 1994: 176:23-31.
10. Nölle B, Specks U, Liidemann J, Rohrbach MS, DeRemce RA, Gross WL: Anticytoplasmic autoantibodies: Their immunodiagnostic value in Wegener's granulomatosis. Ann Intern Med 1989:111:28-40.
11. Hauschild S, Schmitt WH, Csemok E, Flesch BK, Rautmann A, Gross WL: ANCA in systemic vasculitides. collagen vascular diseases, rheumatic disorders and inflammatory bowel diseases; in: Gross WL (ed): ANCA-Associated Vasculitides. New York. Plenum. 1993, pp 245-251.
12. Gross WL, Csemok E: Immunodiagnostic and pathophysiologic aspects of antineutrophil cytoplasmic antibodies in vasculitis. Curr Opin Rheumatol 1995;7:11-19.
13. Jayne DRW, Gaskin G, Pusey CD, Lockwood CM: ANCA and predicting relapse in systemic vasculitis. QJ Med 1995;88:127-133.
14. Cohen Tervaert JW, van der Woude FJ, Fauci AS, Ambras AL, Vclosa J, Keane WF, Meijer S. van der Giessen M, The T, van der Ilern GK, Kallenberg CGM: Association between active Wegener's granulomatosis and anticytoplasmic antibodies. Arch Intem Med 1989:149:2461-2465.
15. Reinhold-Keller E, Kekow J, Schnabel A, Schmitt WH, Heller M, Beigel A, Duncker G, Gross WL: Influence of disease manifestation and antincutrophil cytoplasmic antibody titer in the response to pulse cyclophosphamide therapy in patients with Wegener's granulomatosis. Arthritis Rheum 1994;37:919-924.
16. Markey BA. Warren JS: Use of anti-neutrophil cytoplasmic antibody assay to distinguish between vasculitis disease activity and complications of cytotoxic therapy. Am J Clin Pathol 1994:102:589-594.
17. Klinkenborg A, Reinhold-Keller E. Csemok E, Gross WL: Antineutrophil cytoplasmic antibodies (ANCA) in Churg-Strauss syndrome (CSS), prevalence, specifitics and clinical significance (abstract). Arthritis Rheum 1994: 37:S267.
18. Guillevain L, Visser H, Noel LH, Pourrat J, Vernier I, Gayraud M, Oksman F, Lesavre P: antineutrophil cytoplasm antibodies in systemic polyarteritis nodosa with and without hepatitis B virus infection and Churg-Strauss syndrome -62 patients. J Rheumatol 1993;20:1345-1349.
19. Falk RJ. Jennettc JC: Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. N Engl J Med 1988:318: 1651-1657.
20. Jennette JC. Falk R. Andrassy K. Bacon PA. Churg J. Gross WL, Hagen EC. Floffman GS, Hunder GG. Kallenberg CGM. McCluskey RT, Sinico RA. Rees AJ. van Es LA. Waldhcrr R. Wiik A: Nomenclature of systemic vasculitides. Proposal of an international conference. Arthritis Rheum 1994:37:187-192.
21. Gross WL, Csemok E, Heimchen U: Antincutrophil cytoplasmic autoantibodies, autoantigens. and systemic vasculitis. APMIS 1995; 103:81-97.
22. Cohen Tervaert JW, Goldschmeding R, Elenta JD, van der Giessen M, Huitema MG, van der Hem GK, The TH, von dem Borne AEGKR, Kallenberg CGM: Autoantibodies against myeloid lysosomal enzymes in crescentic glomerulonephritis. Kidney Int 1990;37:799-806.
23. Jayne DRW, Marshall PD, Jones SJ, Lockwood CM: Autoantibodies to GBM and neutrophil cytoplasm in rapidly progressive glomerulonephritis. Kidney lnt 1990;37:965-970.
24. Weiss J. Elsbach P. Olsson I, Odeberg H: Purification and characterization of a potent bactericidal and membrane active protein from the granules of human polymorphonuclear leukocytes. .1 Biol Chem 1978;253:2664-2672.
25. Zhao MH, Jones SJ, Lockwood CM: Bactericidal/permeability increasing protein (BPI) is an important antigen for anti-neutrophil cytoplasmic autoantibodies (ANCA) in vasculitis. Clin Exp Immunol 1995;99:49-56.
26. Herzberg C. Csemok E, Stoffel M, Carroll SF, Szymkowiak C, Gross WL: Disease associations of ANCA with specifictiy for bactericidal/permeability increasing protein (BPI) (abstract), Clin Exp Immunol 1995:101 (suppl 1): 4L
27. Mulder AHL. Horst G. van Lceuwen A. Limburg PC. Kallenberg CGM: Antineutrophil cytoplasmic antibodies in rheumatoid arthritis. Characterization and clinical correlations. Arthritis Rheum 1993:36:1054-1060.
28. Coremans IEM, Hagen EC, Daha MR, van der Woude FJ, van der Voort EAM, Kleijburg-van der Keur C, Breedveld FC: Antilactoferrin antibodies in patients with arthritis are associated with vasculitis. Arthritis Rheum 1992:35: 1466-1475.
29. Schnabel A. Csemok E. Isenberg DA. Mrowka C. Gross WL: Antineutrophil cytoplasmic antibodies in systemic lupus erythematosus - Prevalence. specificities and clinical associations. Arthritis Rheum 1994;38:633-637.
30. Cambridge G, Wallace H, Bernstein RM, Leaker B: Autoantibodies to myeloperoxidase in idiopathic and drag-induced systemic lupus erythematosus and vasculitis. Br J Rheumatol 1994:33:109-114.
31. Yang H, Rotter JI, Toyoda H, Landers C, Tyan D, MeElree CK, Targan SR: Ulcerative colitis: A genetically heterogeneous disorder defined by genetic (HLA class II) and subclinical (antineutrophil cytoplasmic antibodies) markers. J Clin Invest 1993:92:1080-1084.
32. Mulder AHL, Horst G, Haagsma EB, Limburg PC, Kleinbeuker JH, Kallenberg CGM: Prevalence and characterization of anti-neutrophil cytoplasmic antibodies in autoimmune liver diseases. Hepatology 1993; 17:411-417.